Podcast: "Funding Europe's Biotech Ecosystem for Success"

This podcast provides vital insights into the pressing issues facing EU biotech businesses, and provides some answers that tackle Europe's funding issues.
 
Anthony Attia, CEO of Euronext Paris and Head of Listings for the Group; Thomas Dyrberg, Managing Partner of Novo A/S; and Poul Sørensen, Global Head Strategy & PMO of Stallergenes Greer plc and chair of EBE's working group on Innovation and Funding Models; sat together to discuss the recently released EBE position paper Europe's flawed and underfunded biotech ecosystem.
 
                                        
 Anthony Attia                 Poul Sørensen               Thomas Dyrberg
 
Listen to the podcast here
Read the EBE Position paper on "Europe's flawed and underfunded biotech ecosystem" here